Jasper Therapeutics
Enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
* | $50.0m | Post IPO Equity | |
| Total Funding | 000k | ||
Citadel(exited)
TSVC(exited)
Abingworth(exited)
Metalmark Capital(exited)
Avego Bioscience Capital(exited)
Qiming Venture Partners USA(exited)
Surveyor Capital(exited)
Roche Venture Fund(exited)
Alexandria Venture Investments(exited)
Federated Hermes(exited)
Avego(exited)
| USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.